Logotype for Fresenius Medical Care AG

Fresenius Medical Care (FME) investor relations material

Fresenius Medical Care Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Fresenius Medical Care AG
Q3 2025 earnings summary4 Nov, 2025

Executive summary

  • Achieved 10% organic revenue growth in Q3 2025, with all operating segments contributing positively.

  • Operating income grew 28% at constant currency, with margin expanding to 11.7% (excluding special items).

  • Net income attributable to shareholders increased 29% to €275M, with EPS up 30%.

  • FME25+ and SME Reignite strategies advanced, generating €47M in Q3 savings and €174M year-to-date.

  • Share buyback program launched, with €188M invested for 4.35M shares by October 31, 2025.

Financial highlights

  • Q3 2025 revenue: €4,885M (+3% reported, +8% at constant currency, +10% organic).

  • Q3 operating income: €477M (+3% reported, +8% at constant currency); margin 9.8% reported, 11.7% excluding special items.

  • Q3 net income: €275M (+29% reported); EPS: €0.94.

  • Free cash flow for Q3: €550M, down 33% YoY due to prior year’s one-off inflow.

  • Net leverage ratio improved to 2.6x, within target range of 2.5–3x.

Outlook and guidance

  • FY 2025 outlook confirmed: revenue growth expected to be positive to low-single digit percent.

  • Operating income (excluding special items) projected to grow in the high-teens to high-twenties percent range.

  • Fourth quarter expected to be the strongest, with further acceleration in earnings and margin expansion.

  • FME25+ Program savings target increased to €1.05B by end of 2027.

  • 2026 outlook to be provided with full-year results in February.

FME25+ program net financial benefit by 2027?
Value-Based Care segment profitability timeline?
Portfolio optimization expected long-term benefits?
HVHDF rollout: operational benefits observed
Key headwinds impacting underlying profitability
Value-Based Care: path to profitable growth
HVHDF rollout impact on 2026 volumes?
Phosphate binder contribution beyond 2025?
Path to 2% US treatment growth in 2026?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Fresenius Medical Care earnings date

Logotype for Fresenius Medical Care AG
Q4 202524 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Fresenius Medical Care earnings date

Logotype for Fresenius Medical Care AG
Q4 202524 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Fresenius Medical Care AG & Co. KGaA operates dialysis centers in Germany, North America, and internationally. It offers services for treatment of chronic kidney disease, including hemodialysis and peritoneal dialysis. The company integrates health care for people with chronic kidney failure through its offering of inpatient and outpatient care, which includes the use of advanced technologies, including the Hemodialysis Integrated Technology system from Fresenius, regenerative medicine products from Ageneron, and blood purification products from AlloMap. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage